The financing will go toward ongoing commercialization of the firm's autoimmune tests and therapeutics promotion business.
Variantyx, a 2014 spinout from Tel Aviv University that is based in Framingham, Massachusetts, provides clinical genomic testing for screening and rare disease diagnostics.
BioMérieux has increased its stake in Chinese immunoassay developer Hybiome Biomedical Engineering from 54 percent to 67 percent.
The new funding brings the Series B total to £23.3 million for the British clinical decision support technology developer.
The company envisions creating a "vocometer … to provide disease screening and management solutions based on acoustic analysis of seconds of voice."
Clinical informatics startup Ovation looks to grow its business in laboratory information systems for precision molecular diagnostic labs.
The firm said it raised €55.5 million to fund the expansion of its Idylla test platform, its sales and marketing activities, and other general corporate purposes.
The Belgium-based firm plans to use the proceeds to fund expansion of the Idylla test platform, sales and marketing activities, and additional general corporate purposes.
The Series E financing will go, in part, toward expansion of the company's US presence by growing its workforce and marketing to more American hospitals.
The funding will go toward expanding the firm's product line and increasing access to its testing services. MyLab Box has raised $2.1 million in total.